Nephrology Journal Club

👀Seek and you shall FIND 🔎 #ERA26 #NephTwitter FIND-CKD asks if finerenone is beneficial in patients with non-diabetic CKD. Blog by @ManoleaA & @DivyaveerSSNeph nephjc.com/news/2026/7/6/…

Whoops minor error! Here's post one! #NephJC #TenPostNephJC FIND-CKD asks: Can we extend nsMRA cardiorenal benefits to the massive population with CKD without diabetes? Let’s FIND out! 🔍 Read the article 👇: pubmed.ncbi.nlm.nih.gov/42246672/ 1/10🧵

The Takeaway 💡 The future of non-diabetic CKD care is looking increasingly multi-drug too! 💊 ➡️Up next 8/4/26: Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock (The SODa-BIC Investigators, NEJM, 2026) Join us nephjc.com 10/10

I want more info: nephjc.com/news/2026/7/17… nephjc.com/news/2026/7/20… @ManoleaA @DivyaveerSSNeph @rn_flex @DrBarbaTeba 9/10

I want more info: nephjc.com/news/2026/7/17… nephjc.com/news/2026/7/20… @manoleaandreea @DivyaveerSSNeph @rn_flex @DrBarbaTeba 9/10

Want more?? #NephTwitter 🩳FIND-CKD shorts from @CristinaDeReins Finerenone in glomerulonephritis & a pooled analysis of safety and efficacy in CKD (INFINITY) nephjc.com/news/2026/7/20…

¿Está la finerenona lista para ir más allá de la diabetes? El resumen visual @DrBarbaTeba @dra_miliflores #NephJC #NephTwitter nephjc.com/news/2026/7/17…

🔍FIND-CKD🔎 💊Use of finerenone in non-diabetic CKD #NephJC #NephTwitter #ERA26 VA by @DrBarbaTeba nephjc.com/news/2026/7/17…

#NephJC Shorts is our new way to share quick takes on notable studies we can’t cover fully 👇👇Check the updated blog page for upcoming Shorts and those already published ✨Suggestions and feedback welcome nephjc.com/nephjc-shorts

10/10 Final thoughts Even negative trials can be informative. Use of DOACs in CKD increase bleeding without added CV benefits. Next up: Finerenone in Persons with Chronic Kidney Disease without Diabetes (FIND CKD) NEJM, June 2026 Join us at nephjc.com

9/10 I want more info Blog by @Cristina De Reins and @DrSaiVani1 VA by @DrSaiVani1 nephjc.com/news/2026/7/6/… nephjc.com/news/2026/7/6/…

#NephJC #TenPostNephJC. #NephTwitter 1/10 Patients with CKD have ⬆️ CVD & bleeding risks but are often excluded from antithrombotic trials, creating a 🔑 evidence gap. Can low dose rivaroxaban safely improve CV outcomes? pubmed.ncbi.nlm.nih.gov/42240165/